KURIAZ Trademark

Trademark Overview


On Thursday, December 4, 2014, a trademark application was filed for KURIAZ with the United States Patent and Trademark Office. The USPTO has given the KURIAZ trademark a serial number of 86471390. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 8, 2018. This trademark is owned by Eli Lilly and Company. The KURIAZ trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases in food producing animals and livestock, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, and metabolic diseases in animals, namely, Ketosis, Brucellosis, hypomagnesaemia, milk fever, fat cow syndrome, E. Coli, salmonella, mad cow disease, Cryptosporidium, Campylobacter, bacillus anthracis; animal feed supplements; antimicrobials for inhibiting microbiological decomposition in food and animal feed for food safety and food animal processing; antimicrobials for cleaning the animal during food animal processing; pathogen reduction treatment preparation for use on treating bacteria contaminants in meat which may be found in the livestock's digestive systems, or on the livestock during the harvest and processing phases; medicated animal feed and water additives in the nature of die...
kuriaz

General Information


Serial Number86471390
Word MarkKURIAZ
Filing DateThursday, December 4, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 8, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 7, 2015

Trademark Statements


Goods and ServicesVeterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases in food producing animals and livestock, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, and metabolic diseases in animals, namely, Ketosis, Brucellosis, hypomagnesaemia, milk fever, fat cow syndrome, E. Coli, salmonella, mad cow disease, Cryptosporidium, Campylobacter, bacillus anthracis; animal feed supplements; antimicrobials for inhibiting microbiological decomposition in food and animal feed for food safety and food animal processing; antimicrobials for cleaning the animal during food animal processing; pathogen reduction treatment preparation for use on treating bacteria contaminants in meat which may be found in the livestock's digestive systems, or on the livestock during the harvest and processing phases; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; Veterinary hormone preparations and hormone preparation implants for animals, namely, progesterone, estrogen and testosterone; Veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat and to inhibit microbial decomposition in food and animal feed; veterinary preparations, namely, medical diagnostic agents, tests, and preparations and substances to identify pathogens and residues of biological interest for veterinary use; Veterinary preparations for companion animals, namely, to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, namely, cerebellar hypoplasia, cerebellar abiotrophy, laryngeal paralysis, meningoencephalitis, syringomyelia, neurological and neurodegenerative disorders, namely, seizure, epilepsy, neuropathies, cardiovascular conditions, dermatologic conditions, namely, canine atopic dermatitis, skin rash, flea allergy, food allergy, cancer, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections associated with acaricides, heartworm, GI nematodes, mange, fleas, allergy atopic conditions, liver diseases and disorders, namely, jaundice, hepatic encephalopathy and nonsurgical sterilization, namely, hormones for the control/prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely, vaccines for companion animals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 11, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameELANCO US INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressGREENFIELD, IN 46140

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Tuesday, October 9, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 8, 2018ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 28, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 14, 2018EXTENSION 5 GRANTED
Tuesday, February 13, 2018EXTENSION 5 FILED
Tuesday, February 13, 2018TEAS EXTENSION RECEIVED
Saturday, August 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 17, 2017EXTENSION 4 GRANTED
Thursday, August 17, 2017EXTENSION 4 FILED
Thursday, August 17, 2017TEAS EXTENSION RECEIVED
Tuesday, March 28, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 28, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, February 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2017EXTENSION 3 GRANTED
Thursday, February 23, 2017EXTENSION 3 FILED
Thursday, February 23, 2017TEAS EXTENSION RECEIVED
Wednesday, September 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 20, 2016EXTENSION 2 GRANTED
Wednesday, August 31, 2016EXTENSION 2 FILED
Monday, September 19, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 31, 2016TEAS EXTENSION RECEIVED
Thursday, December 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 15, 2015EXTENSION 1 GRANTED
Tuesday, December 15, 2015EXTENSION 1 FILED
Tuesday, December 15, 2015TEAS EXTENSION RECEIVED
Tuesday, September 1, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 7, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 7, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 17, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 4, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 29, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 29, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 22, 2015ASSIGNED TO LIE
Wednesday, May 20, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 2, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 2, 2015NON-FINAL ACTION E-MAILED
Monday, March 2, 2015NON-FINAL ACTION WRITTEN
Friday, February 27, 2015ASSIGNED TO EXAMINER
Thursday, December 11, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 8, 2014NEW APPLICATION ENTERED IN TRAM